Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Variants in ACPP are associated with cerebrospinal fluid Prostatic Acid Phosphatase levels.

Staley LA, Ebbert MT, Bunker D, Bailey M; Alzheimer’s Disease Neuroimaging Initiative, Ridge PG, Goate AM, Kauwe JS.

BMC Genomics. 2016 Jun 29;17 Suppl 3:439. doi: 10.1186/s12864-016-2787-y.

2.

Variants in CCL16 are associated with blood plasma and cerebrospinal fluid CCL16 protein levels.

Ebbert MT, Staley LA, Parker J, Parker S, Bailey M; Alzheimer’s Disease Neuroimaging Initiative, Ridge PG, Goate AM, Kauwe JS.

BMC Genomics. 2016 Jun 29;17 Suppl 3:437. doi: 10.1186/s12864-016-2788-x.

3.

Genome-wide association study of prolactin levels in blood plasma and cerebrospinal fluid.

Staley LA, Ebbert MT, Parker S, Bailey M; Alzheimer’s Disease Neuroimaging Initiative, Ridge PG, Goate AM, Kauwe JS.

BMC Genomics. 2016 Jun 29;17 Suppl 3:436. doi: 10.1186/s12864-016-2785-0.

4.

SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.

Cruchaga C, Kauwe JS, Mayo K, Spiegel N, Bertelsen S, Nowotny P, Shah AR, Abraham R, Hollingworth P, Harold D, Owen MM, Williams J, Lovestone S, Peskind ER, Li G, Leverenz JB, Galasko D; Alzheimer's Disease Neuroimaging Initiative, Morris JC, Fagan AM, Holtzman DM, Goate AM.

PLoS Genet. 2010 Sep 16;6(9):e1001101. doi: 10.1371/journal.pgen.1001101.

5.

Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.

Han MR, Schellenberg GD, Wang LS; Alzheimer's Disease Neuroimaging Initiative.

BMC Neurol. 2010 Oct 8;10:90. doi: 10.1186/1471-2377-10-90.

6.

The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.

Schjeide BM, Schnack C, Lambert JC, Lill CM, Kirchheiner J, Tumani H, Otto M, Tanzi RE, Lehrach H, Amouyel P, von Arnim CA, Bertram L.

Arch Gen Psychiatry. 2011 Feb;68(2):207-13. doi: 10.1001/archgenpsychiatry.2010.196.

PMID:
21300948
7.

Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.

Kettunen P, Larsson S, Holmgren S, Olsson S, Minthon L, Zetterberg H, Blennow K, Nilsson S, Sjölander A.

J Alzheimers Dis. 2015;44(4):1313-22. doi: 10.3233/JAD-142025.

PMID:
25420549
8.

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites.

Brouwers N, Van Cauwenberghe C, Engelborghs S, Lambert JC, Bettens K, Le Bastard N, Pasquier F, Montoya AG, Peeters K, Mattheijssens M, Vandenberghe R, Deyn PP, Cruts M, Amouyel P, Sleegers K, Van Broeckhoven C.

Mol Psychiatry. 2012 Feb;17(2):223-33. doi: 10.1038/mp.2011.24. Epub 2011 Mar 15.

9.

Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.

von Otter M, Bergström P, Quattrone A, De Marco EV, Annesi G, Söderkvist P, Wettinger SB, Drozdzik M, Bialecka M, Nissbrandt H, Klein C, Nilsson M, Hammarsten O, Nilsson S, Zetterberg H.

BMC Med Genet. 2014 Dec 12;15:131. doi: 10.1186/s12881-014-0131-4.

10.

Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta.

Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, Goate AM.

Neurogenetics. 2009 Feb;10(1):13-7. doi: 10.1007/s10048-008-0150-4. Epub 2008 Sep 24.

11.

Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.

Liu G, Bao X, Jiang Y, Liao M, Jiang Q, Feng R, Zhang L, Ma G, Chen Z, Wang G, Wang R, Zhao B, Li K.

Mol Neurobiol. 2015 Dec;52(3):1629-1636. doi: 10.1007/s12035-014-8946-8. Epub 2014 Nov 5.

PMID:
25370933
12.

ABCB1 genotype and CSF beta-amyloid in Alzheimer disease.

Kohen R, Shofer JB, Korvatska O, Petrie EC, Wang LY, Schellenberg GD, Peskind ER, Wilkinson CW.

J Geriatr Psychiatry Neurol. 2011 Jun;24(2):63-6. doi: 10.1177/0891988711402325. Epub 2011 Apr 8.

13.

CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer's Disease.

Zhang DF, Li J, Wu H, Cui Y, Bi R, Zhou HJ, Wang HZ, Zhang C, Wang D; Alzheimer's Disease Neuroimaging Initiative (ADNI), Kong QP, Li T, Fang Y, Jiang T, Yao YG.

Neuropsychopharmacology. 2016 Mar;41(4):1034-45. doi: 10.1038/npp.2015.232. Epub 2015 Aug 5.

14.

Replication of prostate cancer risk loci in a Japanese case-control association study.

Yamada H, Penney KL, Takahashi H, Katoh T, Yamano Y, Yamakado M, Kimura T, Kuruma H, Kamata Y, Egawa S, Freedman ML.

J Natl Cancer Inst. 2009 Oct 7;101(19):1330-6. doi: 10.1093/jnci/djp287. Epub 2009 Sep 2.

PMID:
19726753
15.

Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease.

Bekris LM, Millard S, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Yu CE, Peskind ER.

Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):874-83. doi: 10.1002/ajmg.b.32094. Epub 2012 Aug 27.

16.

Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort.

Elias-Sonnenschein LS, Helisalmi S, Natunen T, Hall A, Paajanen T, Herukka SK, Laitinen M, Remes AM, Koivisto AM, Mattila KM, Lehtimäki T, Verhey FR, Visser PJ, Soininen H, Hiltunen M.

PLoS One. 2013;8(4):e59676. doi: 10.1371/journal.pone.0059676. Epub 2013 Apr 3.

17.

Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels.

Kauwe JS, Cruchaga C, Bertelsen S, Mayo K, Latu W, Nowotny P, Hinrichs AL, Fagan AM, Holtzman DM; Alzheimer's Disease Neuroimaging Initiative, Goate AM.

J Alzheimers Dis. 2010;21(3):833-42. doi: 10.3233/JAD-2010-091711.

18.

Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.

Orozco G, Goh CL, Al Olama AA, Benlloch-Garcia S, Govindasami K, Guy M, Muir KR, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Kote-Jarai Z, Easton DF, Eyre S, Eeles RA.

BJU Int. 2013 Jun;111(7):1148-55. doi: 10.1111/j.1464-410X.2012.11492.x. Epub 2012 Sep 18.

19.

Endometrial vezatin and its association with endometriosis risk.

Holdsworth-Carson SJ, Fung JN, Luong HT, Sapkota Y, Bowdler LM, Wallace L, Teh WT, Powell JE, Girling JE, Healey M, Montgomery GW, Rogers PA.

Hum Reprod. 2016 May;31(5):999-1013. doi: 10.1093/humrep/dew047. Epub 2016 Mar 22.

PMID:
27005890
20.

Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel.

Kim S, Swaminathan S, Inlow M, Risacher SL, Nho K, Shen L, Foroud TM, Petersen RC, Aisen PS, Soares H, Toledo JB, Shaw LM, Trojanowski JQ, Weiner MW, McDonald BC, Farlow MR, Ghetti B, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

PLoS One. 2013 Jul 23;8(7):e70269. doi: 10.1371/journal.pone.0070269. Print 2013.

Supplemental Content

Support Center